Hypertrol Tablet
Natural health product licensed in Canada
- Other names
- Carditrol Tablet
- Licence holder
- Viva Pharmaceutical Inc.
- NPN or DIN-HM
- 80129982
- Status
- Inactive licence
- Licence date
- 6 March 2024
- Revision date
- 2 February 2026
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Dose déclarée au-delà d'une limite
Chrome: up to 100 µg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Melissa officinalis Source : Melissa officinalis - Herb top Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 400 mg | 100 mg | Not calculated |
| Chrome Source : Produit de chélation de chrome (III) et de protéine végétale hydrolysée (PVH) | 100 microgram | 100 µg |
| Magnésium Source : Oxyde de magnésium | 200 mg | 200,000 µg |
Non-medicinal ingredients
Talc, Annatto, Cellulose microcristalline, Dioxyde de silicium, Poly(alcool vinylique), Poly(éthylène glycol), Carmine, Poudre de caroube, Dioxyde de titane, Croscarmellose de sodium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Melissa officinalis is traditionally used in Herbal Medicine to help relieve digestive disturbances such as dyspepsia. Contributes to maintaining general health. Multi-mineral supplement. Source of (an) antioxidant(s)/Provides (an) antioxidant(s). Crataegus laevigata is traditionally used in Herbal Medicine to help maintain and/or support cardiovascular health in adults.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80129982
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.